Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality

Cancer

Volumn 110, Issue 1, 2007, Pages 96-102

  Ali, Naeem A ^a,b   O'Brien Jr , James M ^a   Blum, William ^a   Byrd, John C ^a   Klisovic, Rebecca B ^a   Marcucci, Guido ^a   Phillips, Gary ^a   Marsh, Clay B ^a   Lemeshow, Stanley ^a   Grever, Michael R ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Acute myeloid leukemia; Hyperglycemia; Mortality; Outcomes; Sepsis

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER MORTALITY; COHORT ANALYSIS; CYTOGENETICS; DIABETES MELLITUS; DISEASE FREE SURVIVAL; FEMALE; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; STATISTICAL ANALYSIS;

ACUTE DISEASE; ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; OHIO; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; SEPSIS; SURVIVAL RATE; TIME FACTORS;

EID: 34250853452     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22777     Document Type: Article

References (22)

1. Acute myeloid leukemia. AML reference information. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/adultAML/HealthProfessional Accessed October 31, 2006.
2. Sheinberg DA, Maslak PG, Weiss MA. Acute Leukemias. In: DeVita VT Jr, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology, 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005:2088-2166.
3. Pizzo PA. Fever in immunocompromised patients. N Engl J Med. 1999;341:893-900.
4. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64:328-340.
5. Chang HY, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ. Causes of death in adults with acute leukemia. Medicine (Baltimore). 1976;55:259-268.
6. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
7. Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038-3051.
8. Inzucchi SE. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355:1903-1911.
9. Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33:1624-1633.
10. Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30:748-756.
11. Walrand S, Guillet C, Boirie Y, Vasson MP. In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions. J Leukoc Biol. 2004;76:1104-1110.
12. Saiepour D, Sehlin J, Oldenborg PA. Hyperglycemia-induced protein kinase C activation inhibits phagocytosis of C3b- and immunoglobulin g-opsonized yeast particles in normal human neutrophils. Exp Diabesity Res. 2003;4:125-132.
13. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140-2144.
14. Pinto DS, Skolnick AH, Kirtane AJ, et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;46:178-180.
15. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
16. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Eng J Med. 2006;354:449-461.
17. Weiser MA, Cabanillas ME, Konopleva M, et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer. 2004;100:1179-1185.
18. Byrd JC, Mrozek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002;100:4325-4336.
19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
21. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-1554.
22. van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151-3159.